Wire Screener Dashboard Go Pro

Watchlist

--

--

--

--

Get Started Log In Not investment advice. Past performance ≠ future results.

Loading…

Wire Screener Dashboard

Stocks›Basic Materials›DFTX

DFTX

Definium Therapeutics, Inc.

NasdaqResearch view

Basic Materials · Medicinal Chemicals & Botanical Products

OverviewFundamentals Latest filings ↗

Price history

Interactive · live data via TradingView

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR

Revenue—

Net Income—

Gross Profit—

Oper Income—

EPS (dil)—

Rev/sh—

FCF/sh—

Book/sh—

Cash/sh—

Gross M—

Oper M—

Profit M—

FCF M—

ROE—

ROA—

ROIC—

R&D/Rev—

Rev Y/Y—

Rev 3Y CAGR—

EPS Y/Y—

EPS 3Y CAGR—

FCF 3Y CAGR—

Payout—

Div/sh—

Shs Chg Y/Y—

Current Ratio—

Quick Ratio—

Debt/Eq—

Int Coverage—

Net Debt—

Total Debt—

Cash & Eq—

Total Assets—

Oper CF—

Capex—

Free CF—

Buybacks—

Equity—

Liabilities—

Shs Outstand—

SectorBasic Materials

🔒 P/E—

🔒 Fwd P/E—

🔒 P/S—

🔒 P/B—

🔒 Market Cap—

🔒 Div Yield—

🔒 52W Range—

🔒 Beta—

40+ fundamentals from SEC EDGAR (public domain) — deeper than a typical screener's ratio table.

Revenue & Earnings — fiscal year

Revenue history unavailable.

COMMUNITY · $DFTX0 theses

POST YOUR TAKE →

Related Stocks

Loading peers…

Ask AI about DFTX Build basket with DFTX Screener

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.

DFTX Definium Therapeutics, Inc. Stock — fundamentals, financials & AI research · AlgoThesis